Ingrid Pretsch
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).
Journal: Intensive care medicine
Published: March 12, 2024
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
Journal: European heart journal
Published: October 09, 2021
Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study.
Journal: Scientific reports
Published: May 12, 2021
Thinking fast and slow: lactate and MELD-XI (model for end-stage liver disease excluding INR) are useful for estimating mortality after cardiopulmonary resuscitation.
Journal: Minerva anestesiologica
Published: May 03, 2021
Mortality after cardiopulmonary resuscitation on a medical ICU : A sex-specific outcome analysis.
Journal: Wiener klinische Wochenschrift
Published: August 21, 2020
Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.
Journal: Scottish medical journal
Published: July 21, 2019
Successful long-term antibiotic suppressive therapy in a case of prosthetic valve endocarditis and a case of extensive aortic and subclavian graft infection.
Journal: Infection
Published: April 10, 2019
Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: February 24, 2019
Two cases of serious rhabdomyolysis during linezolid treatment.
Journal: Infection
Published: December 08, 2016
Global research trends in the medical therapy of pulmonary arterial hypertension 2000-2014.
Journal: Pulmonary pharmacology & therapeutics
Published: April 22, 2016
Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial).
Journal: Heart, lung & circulation
Published: April 13, 2016
Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial.
Journal: Wiener klinische Wochenschrift
Published: January 18, 2016
Last Updated: 09/26/2026